India to add HPV vaccination to National Immunisation Programme

India plans to include the Serum Institute of India's Cervavac HPV vaccine in the National Immunisation Programme after 2027, pending successful single-dose clinical trial results. The move aims to expand cervical cancer prevention, improve vaccine coverage among adolescent girls, reduce healthcare costs, and strengthen the country's long-term public health strategy.